US FDA Grants CLIA Waiver for FebriDx
Filed with ASX · · 4 pages · English
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings CallLumos Diagnostics Holdings Ltd. on 6ix
In the deck
Story so far
Earlier from Lumos Diagnostics
- Trading Halt
- Lumos Delivers Several Pivotal Milestones in 1H FY26
- Appendix 4D and Half Year Report
- Lumos Completes Enrolment Milestone for Paediatric Study
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Lumos Diagnostics
- Lumos completes $20m placement and launches SPP
- Investor Presentation
- Lumos receives largest FebriDx order to date
- Lumos secures new contract manufacturing agreement
- Prospectus
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics